| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/06/2006 | WO2006069752A2 Device and method for the locally resolved chemical stimulation |
| 07/06/2006 | WO2006069429A1 Wnt4 in supporting lymphopoiesis |
| 07/06/2006 | WO2006069413A2 Method for isolating cells and viruses |
| 07/06/2006 | WO2006040764A3 System and method for production of antibodies in plant cell culture |
| 07/06/2006 | WO2006031689A3 Multimeric constructs |
| 07/06/2006 | WO2006013159A3 Method for isolating and culturing stem cells |
| 07/06/2006 | WO2006010146A3 Functional variant of lymphoid tyrosine phosphatase is associated with autoimmune disorders |
| 07/06/2006 | WO2006007202A3 Canine cd20 compositions |
| 07/06/2006 | WO2006003215A3 Targeted transgenesis of short hairpin rna expression cassettes using recombinase mediated cassette exchange |
| 07/06/2006 | WO2006000830A3 Cells expressing a modified t cell receptor |
| 07/06/2006 | WO2005116072A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 07/06/2006 | WO2005082077A3 Novel bacillus thuringiensis crystal polypeptides, polynucleotides, and compositions thereof |
| 07/06/2006 | WO2005049639A3 Compositions and methods for protein isolation |
| 07/06/2006 | WO2005017111A3 Methods and systems for identifying micro-rna targets and synthesizing novel micro-rnas and uses of the same |
| 07/06/2006 | WO2005003317A3 Engineered blood vessels |
| 07/06/2006 | WO2004061079A3 Candida kefyr cytosine deaminase |
| 07/06/2006 | WO2004043232A3 Methods for identifying risk of melanoma and treatments thereof |
| 07/06/2006 | WO2003072718A3 In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization |
| 07/06/2006 | US20060150283 Sequence-determined DNA fragments and corresponding polypeptides encoded thereby |
| 07/06/2006 | US20060150282 Expression cassettes for the bi-directional transgenic expression of nucleic acids in plants |
| 07/06/2006 | US20060150277 Inbred corn line PHCMV |
| 07/06/2006 | US20060150276 Insecticidal proteins; biological pest control; genetic molecules encoding plant floral defensin-like molecules and their use in generating transgenic plants having resistance or at least reduced sensitivity to plant pests |
| 07/06/2006 | US20060150275 Inbred corn line PHB00 |
| 07/06/2006 | US20060150272 Inbred maize line 413A |
| 07/06/2006 | US20060150270 Genes conferring herbicide resistance |
| 07/06/2006 | US20060150269 Nucleic acid molecules corresponding to glyphosate resistant nucleic acid sequences; conferring herbicide resistance to bacteria, plants, plant cells, tissues; genes conferring glyphosate resistance by formation of non-toxic products |
| 07/06/2006 | US20060150268 Plant-derived transferase genes |
| 07/06/2006 | US20060149392 Biomaterials for guided tissue regeneration and drug delivery |
| 07/06/2006 | US20060149297 Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation |
| 07/06/2006 | US20060149048 Comprises nucleotide sequences coding prostaglandin h synthase for treatment of inflammation; antiinflammatory agents; cytoprotective agents |
| 07/06/2006 | US20060149038 PRO211 polypeptides |
| 07/06/2006 | US20060148709 Neuroprotective properties of GDF-15, a novel member of the TGF-Beta superfamily |
| 07/06/2006 | US20060148692 Novel protein and its dna |
| 07/06/2006 | US20060148086 Vault and vault-like carrier molecules |
| 07/06/2006 | US20060148085 High yield heterologous expression cell lines for expression of gene products with human glycosylation pattern |
| 07/06/2006 | US20060148084 Effect of growth hormone and IGF-1 on neural stem cells |
| 07/06/2006 | US20060148083 Culturing whole bone marrow from mammal in medium comprising fibroblast growth factor-2 and epidermal growth factor to produce neural progenitor cell carrying gene that effects local production of biological compound, administering to tumor diseased tissue; gene therapy |
| 07/06/2006 | US20060148082 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 07/06/2006 | US20060148081 Multipotent tissue culture for use in cell therapy treatments for diabetes mellitus and nervous system disorders such as Parkinson's disease |
| 07/06/2006 | US20060148080 Methods for supporting and producing human cells and tissues in non-human mammal hosts |
| 07/06/2006 | US20060148079 Isolation and purification of human insulin producing cells for the treatment of insulin dependent diabetes |
| 07/06/2006 | US20060148078 Method of dynamically culturing embryonic stem cells |
| 07/06/2006 | US20060148077 Chondrocyte precursors derived from human embryonic stem cells |
| 07/06/2006 | US20060148076 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/06/2006 | US20060148075 Compositions, methods and systems for preparation of a stem cell-enriched cell population |
| 07/06/2006 | US20060148074 Serum-free mammalian cell culture medium, and uses thereof |
| 07/06/2006 | US20060148061 Protein having L-rhamnose isomerise activity, used to catalyze the production of a rare sugar, D-allose, from D-psicose and a DNA encoding it |
| 07/06/2006 | US20060148056 Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase |
| 07/06/2006 | US20060148035 Host cells containing mannosidase catalytic domains within endoplasmic reticulum or Golgi complex for producing glycoproteins with glycan structures attached in glycoform that serve as substrate for transferases |
| 07/06/2006 | US20060148008 Method of characterizing dendritic cells |
| 07/06/2006 | US20060148007 Using cells which over express g-protein coupled receptors as drug screening tools; high throughput and signal transduction assays |
| 07/06/2006 | US20060148005 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 07/06/2006 | US20060147988 Vertebrate transmembrane protein (UNC-5 protein) for use in diagnosis, prevention and treatment of nervous system disorders |
| 07/06/2006 | US20060147982 32 human secreted proteins |
| 07/06/2006 | US20060147974 Novel Drosophila tumor necrosis factor class molecule ("DmTNF") and variants thereof |
| 07/06/2006 | US20060147973 Polynucleotide encoding a novel human serpin secreted from lymphoid cells, LSI-01 |
| 07/06/2006 | US20060147951 "STRAP" and "STEAP" (six transmembrane epithelial antigen of the prostate) |
| 07/06/2006 | US20060147950 Precursor conversion screening method |
| 07/06/2006 | US20060147937 Isolation of living cells and preparation of cell lines based on detection and quantification of preselected cellular ribonucleic acid sequences |
| 07/06/2006 | US20060147933 Interspecies embryonic stem cell |
| 07/06/2006 | US20060147925 Method of detection |
| 07/06/2006 | US20060147514 Method for introducing antisense oligonucleotides into eucaryotic cells |
| 07/06/2006 | US20060147486 Biodegradable dual porous scaffold wrapped with semi-permeable membrane and tissue cell culture using thereof |
| 07/06/2006 | US20060147477 Immunogenic compositions |
| 07/06/2006 | US20060147464 immunogens; immunololgy; for production of vaccines; able to induce antiserum having neutralizing antibody; neutralization assay; Mareks Disease virus, infectious bronchitis virus, Newcastle disease virus, egg drop syndrome virus, turkey rhinotracheitis virus, or reovirus |
| 07/06/2006 | US20060147462 For diagnostic, prophylactic and therapeutic uses, vaccines against bacterial infections |
| 07/06/2006 | US20060147454 Human serine protease and serpin polypeptides |
| 07/06/2006 | US20060147452 Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 07/06/2006 | US20060147445 Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor |
| 07/06/2006 | US20060147444 Biosynthetic binding proteins for immuno-targeting |
| 07/06/2006 | US20060147437 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/06/2006 | US20060147435 Using glycogen synthase kinase-3 (GSK-3) inhibitors to increase endogenous hematopoietic adult stem cell or progenitor cell population in mammals for treatment of immune related, mesenchymal/mesoderm degenerative and/or neurodegenerative diseases |
| 07/06/2006 | US20060147434 Different dendritic cell subsets |
| 07/06/2006 | US20060147432 Tolerogenic antigen-presenting cells |
| 07/06/2006 | US20060147431 Methods for the treatment of lysosomal storage disorders |
| 07/06/2006 | US20060147430 Adipose-derived stem cells for tissue regeneration and wound healing |
| 07/06/2006 | US20060147427 Method for immunotherapy of tumors |
| 07/06/2006 | US20060147426 Nutrient broth comprising multipotent cells for use in propagation of mesodermal, neuroectodermal, and endodermal cells; tissue engineering |
| 07/06/2006 | US20060147425 Use of enteric glia to promote functional nerve connections |
| 07/06/2006 | US20060147424 Human bone stem cells |
| 07/06/2006 | US20060147377 tumor cell line, reponsive to histone deacetylase inhibitors, transfected with vector containing reporter gene such as fluorescent protein, linked to promotor that also controls expression of protein associated with tumor regression, stabilization of tumor growth or inhibition of metastatic growth |
| 07/06/2006 | US20060147375 Antibodies and related molecules that bind to PSCA proteins |
| 07/06/2006 | US20060146644 System for producing micro-cluster liquids |
| 07/06/2006 | US20060144707 Isolation of sperm cells from other biological materials using microfabricated devices and related methods thereof |
| 07/06/2006 | DE102004062420A1 Verfahren zur Isolierung neuraler Zellen mit Tenascin-R-Verbindungen Method for the isolation of neural cells with tenascin-R compounds |
| 07/06/2006 | DE102004062184A1 Embryonenerhaltende Gewinnung pluripotenter embryonaler Stammzellen, derart gewonnene Stammzellen und Verwendung derselben Embryo-preserving mining of pluripotent embryonic stem cells, stem cells obtained in this way and using the same |
| 07/06/2006 | DE102004061947A1 Verfahren zum Einfrieren und Lagern von Zellen A method for freezing and storing of cells |
| 07/06/2006 | DE102004017484B4 Verfahren zur Herstellung einer biologischen Materialzusammensetzung tierischen Ursprungs A process for producing a biological material composition of animal origin |
| 07/06/2006 | CA2623874A1 Wnt4 in supporting lymphopoiesis |
| 07/06/2006 | CA2594289A1 Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody |
| 07/06/2006 | CA2593374A1 Bioreactor process control system and method |
| 07/06/2006 | CA2592716A1 Methods for supporting and producing human cells and tissues in non-human mammal hosts |
| 07/06/2006 | CA2592396A1 Expansion of definitive endoderm cells |
| 07/06/2006 | CA2592120A1 Non-tumorigenic mdck cell line for propagating viruses |
| 07/06/2006 | CA2592043A1 Methods for regulation of stem cells |
| 07/06/2006 | CA2591599A1 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
| 07/06/2006 | CA2589374A1 Antibodies directed to gpnmb and uses thereof |
| 07/06/2006 | CA2589041A1 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 07/06/2006 | CA2587475A1 Synergistic effect of amlodipine and atorvastatin on aortic endothelial cell nitric oxide release |
| 07/06/2006 | CA2559760A1 Process for the production of fine chemicals |